Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code

Journal of the American Medical Directors Association

Volumn 17, Issue 8, 2016, Pages 675-677

  Cao, Li ^a   Morley, John E ^b  

^a SICHUAN UNIVERSITY   (China)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

CALORIC INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; EDITORIAL; GERIATRICS; HUMAN; ICD-10-CM; MOBILIZATION; MUSCLE FUNCTION; MUSCLE MASS; PHENOTYPE; SARCOPENIA; INTERNATIONAL CLASSIFICATION OF DISEASES;

HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; SARCOPENIA;

EID: 84992129607     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2016.06.001     Document Type: Editorial

References (60)

1. 1 Rosenberg, H., Sarcopenia: Origins and clinical relevance. J Nutr 127 (1997), 990S–991S.
2. 2 Morley, J.E., Baumgartner, R.N., Roubenoff, R., et al. Sarcopenia. J Lab Clin Med 137 (2001), 231–243.
3. 3 Fielding, R.A., Vellas, B., Evans, W.J., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 12 (2011), 249–256.
4. 4 Morley, J.E., Abbatecola, A.M., Argiles, J.M., et al., Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 12 (2011), 403–409.
5. 5 Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39 (2010), 412–423.
6. 6 Chen, L.K., Liu, L.K., Woo, J., et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15 (2014), 95–101.
7. 7 Dam, T.T., Peters, K.W., Fragala, M., et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci 69 (2014), 584–590.
8. 8 Bianchi, L., Ferrucci, L., Cherubini, A., et al. The predictive value of the EWGSOP definition of sarcopenia: Results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 71 (2016), 259–264.
9. 9 Malmstrom, T.K., Miller, D.K., Herning, M.M., Morley, J.E., Low appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle-aged African Americans. J Cachexia Sarcopenia Muscle 4 (2013), 179–186.
10. 10 Cruz-Jentoft, A.J., Landi, F., Schneider, S.M., et al. Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43 (2014), 748–759.
11. 11 Landi, F., Martone, A.M., Calvani, R., Marzetti, E., Sarcopenia risk screening tool: A new strategy for clinical practice. J Am Med Dir Assoc 15 (2014), 613–614.
12. 12 Landi, F., Liperoti, R., Fusco, D., et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 13 (2012), 121–126.
13. 13 Hirani, V., Blyth, F., Naganathan, V., et al. Sarcopenia is associated with incident disability, institutionalization, and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project. J Am Med Dir Assoc 16 (2015), 607–613.
14. 14 Rolland, Y., Lauwers-Cances, V., Cristini, C., et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: The EPIDOS (EPIDemiologie de l'OSteoporose) study. Am J Clin Nutr 89 (2009), 1895–1900.
15. 15 Baumgartner, R.N., Wayne, S.J., Waters, D.L., et al. Sarcopenia obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 12 (2004), 1995–2004.
16. 16 Argiles, J.M., Muscaritoli, M., The three faces of sarcopenia. J Am Med Dir Assoc 17 (2016), 471–472.
17. 17 Van de Bool, C., Gosker, H.R., van den Borst, B., et al. Muscle quality is more impaired in sarcopenic patients with chronic obstructive pulmonary disease. J Am Med Dir Assoc 17 (2016), 415–420.
18. 18 von Haehling, S., Anker, S.D., Doehner, W., et al. Frailty and heart disease. Int J Cardiol 168 (2013), 1745–1747.
19. 19 Ezeoke, C.C., Morley, J.E., Pathophysiology of anorexia in the cancer cachexia syndrome. J Cachexia Sarcopenia Muscle 6 (2015), 287–302.
20. 20 Drey, M., Krieger, B., Sieber, C.C., et al. Motoneuron loss is associated with sarcopenia. J Am Med Dir Assoc 15 (2014), 435–439.
21. 21 Baumgartner, R.N., Waters, D.L., Gallagher, D., et al. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 107 (1999), 123–136.
22. 22 Perry, H.M. III, Horowitz, M., Morley, J.E., et al. Longitudinal changes in serum 25-hydroxyvitamin D in older people. Metabolism 48 (1999), 1028–1032.
23. 23 Morley, J.E., Sarcopenia in the elderly. Fam Pract 29 (2012), i44–i48.
24. 24 Michaud, M., Balardy, L., Moulis, G., et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 14 (2013), 877–882.
25. 25 Morley, J.E., Weight loss in older persons: New therapeutic approaches. Curr Pharm Des 13 (2007), 3637–3647.
26. 26 Morley, J.E., Anorexia of aging: A true geriatric syndrome. J Nutr Health Aging 16 (2012), 422–425.
27. 27 McCully, K.K., Posner, J.D., The application of blood flow measurements to the study of aging muscle. J Gerontol A Biol Sci Med Sci 50 (1995), 130–136.
28. 28 Morley, J.E., Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int 98 (2016), 319–333.
29. 29 Fried, L.P., Tangen, C.M., Walston, J., et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56 (2001), M146–M156.
30. 30 Morley, J.E., Vellas, B., van Kan, G.A., et al. Frailty consensus: A call to action. J Am Med Dir Assoc 14 (2013), 392–397.
31. 31 Morley, J.E., Developing novel therapeutic approaches to frailty. Curr Pharm Des 15 (2009), 3384–3395.
32. 32 Morley, J.E., Sarcopenia: Diagnosis and treatment. J Nutr Health Aging 12 (2008), 452–456.
33. 33 Morley, J.E., von Haehling, S., Anker, S.D., Vellas, B., From sarcopenia to frailty: A road less traveled. J Cachexia Sarcopenia Muscle 5 (2014), 5–8.
34. 34 Mijnarends, D.M., Schols, J.M., Meijers, J.M., et al. Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: Similarities and discrepancies. J Am Med Dir Assoc 16 (2015), 301–308.
35. 35 Morley, J.E., Frailty and sarcopenia: The new geriatric giants. Rev Invest Clin 68 (2016), 59–67.
36. 36 Woo, J., Leung, J., Morley, J.E., Validating the SARC-F: A suitable community screening tool for sarcopenia?. J Am Med Dir Assoc 15 (2014), 630–634.
37. 37 Malmstrom, T.K., Miller, D.K., Smionsick, E.M., et al. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7 (2016), 28–36.
38. 38 Cao, L., Chen, S., Zou, C., et al. A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people. J Nutr Health Aging 14 (2013), 531–532.
39. 39 Malmstrom, T.K., Morley, J.E., SARC-F: A simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14 (2013), 531–532.
40. 40 Woo, J., Leung, J., Morley, J.E., Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc 16 (2015), 247–252.
41. 41 Morley, J.E., Adams, E.V., Rapid geriatric assessment. J Am Med Dir Assoc 16 (2015), 808–812.
42. 42 Morley, J.E., Cao, L., Rapid screening for sarcopenia. J Cachexia Sarcopenia Muscle 6 (2015), 312–314.
43. 43 Bauer, J.M., Verlaan, S., Bautmans, I., et al. Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: A randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 16 (2015), 740–747.
44. 44 Bauer, J., Biolo, G., Cederholm, T., et al. Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE study group. J Am Med Dir Assoc 14 (2013), 542–559.
45. 45 Tieland, M., van de Rest, O., Dirks, M.L., et al. Protein supplementation improves physical performance in frail elderly people: A randomized, double-blind, placebo-controlled trial. J AM Med Dir Assoc 13 (2012), 720–726.
46. 46 Michel, J.P., Sarcopenia: There is a need for some steps forward. J Am Med Dir Assoc 15 (2014), 379–380.
47. 47 Morley, J.E., Anker, S.D., von Haehling, S., Prevalence, incidence, and clinical impact of sarcopenia: Facts, numbers, and epidemiology–Update 2014. J Cachexia Sarcopenia Muscle 5 (2014), 253–259.
48. 48 Ng, T.P., Feng, L., Nyunt, M.S., et al. Nutritional, physical, cognitive, and combination interventions and frailty reversal among older adults: A randomized controlled trial. Am J Med 128 (2015), 1225–1236.e1.
49. 49 Tarazona-Santabalbina, F.J., Gomez-Cabrera, M.C., Perez-Ros, P., et al. A multicomponent exercise intervention that reverses frailty and improves cognition, emotion, and social networking in the community-dwelling frail elderly: A randomized clinical trial. J Am Med Dir Assoc 17 (2016), 426–433.
50. 50 Abizanda, P., Lopez, M.D., Garcia, V.P., et al. Effects of an oral nutritional supplementation plus physical exercise intervention on the physical function, nutritional status, and quality of life in frail institutionalized older adults: The ACTIVNES study. J Am Med Dir Assoc 16 (2015), 439.e9–439.e16.
51. 51 Singh, N.A., Quine, S., Clemson, L.M., et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. J Am Med Dir Assoc 13 (2012), 24–30.
52. 52 Strollo, F., Strollo, G., More, M., et al. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients. Aging Male 16 (2013), 33–37.
53. 53 Kenny, A.M., Kleppinger, A., Annis, K., et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone level, low bone mass, and physical frailty. J Am Geriatr Soc 58 (2010), 1134–1143.
54. 54 Srinivas-Shankar, U., Roberts, S.A., Connolly, M.J., et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: A randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 95 (2010), 639–650.
55. 55 Snyder, P.J., Bhasin, S., Cunningham, G.R., et al. Testosterone Trials Investigators. Effects of testosterone treatment in older men. N Engl J Med 374 (2016), 611–624.
56. 56 Travison, T.G., Basaria, S., Storer, T.W., et al. Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci 66 (2011), 1090–1099.
57. 57 Sih, R., Morley, J.E., Kaiser, F.E., et al. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J Clin Endocrinol Metab 82 (1997), 1661–1667.
58. 58 Albert, S.G., Morley, J.E., Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: A systematic review. Clin Endocrinol (Oxf), 2016 Apr 28 [Epub ahead of print].
59. 59 Morley, J.E., von Heahling, S., Anker, S.D., Are we closer to having drugs to treat muscle wasting disease?. J Cachexia Sarcopenia Muscle 5 (2014), 83–87.
60. 60 Anker, S.D., Coats, A.J., Morley, J.E., Evidence for partial pharmaceutical reversal of the cancer anorexia-cachexia syndrome: The case of anamorelin. J Cachexia Sarcopenia Muscle 6 (2015), 275–277.